Top Markets
Coin of the day
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX
Rank in Stocks #42502
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the... RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.
Share Price
$0.0007
Last synced: 2026-08-11
Market Cap
$1.05K
Change (1 day)
0.00%
Change (1 year)
250.00%
Country
US
Trade RegeneRx Biopharmaceuticals, Inc. (RGRX)

Category

Stock price history for RegeneRx Biopharmaceuticals, Inc. (RGRX)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $110.06 on 2003-10-01
Stock price history of RegeneRx Biopharmaceuticals, Inc. from 2003 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 -97.59%
2024 1,141.64%
2023 -99.99%
2022 -11.40%
2021 -67.94%
2020 258.85%
2019 26.29%
2018 -40.52%
2017 -42.65%
2016 -16.88%
2015 184.48%
2014 141.27%
2013 -42.28%
2012 -20.49%
2011 -48.51%
2010 -59.48%
2009 -54.58%
2008 16.64%
2007 -51.00%
2006 -27.91%
2005 -24.03%
2004 365.32%
2003 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.40%
KR